A quantitative analysis of kinase inhibitor selectivity
- PMID: 18183025
- DOI: 10.1038/nbt1358
A quantitative analysis of kinase inhibitor selectivity
Abstract
Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome. We present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome. The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns. To enable a global analysis of the results, we introduce the concept of a selectivity score as a general tool to quantify and differentiate the observed interaction patterns. We further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.
Similar articles
-
Trends in kinase selectivity: insights for target class-focused library screening.J Med Chem. 2011 Jan 13;54(1):54-66. doi: 10.1021/jm101195a. Epub 2010 Dec 3. J Med Chem. 2011. PMID: 21128601
-
Kinase-kernel models: accurate in silico screening of 4 million compounds across the entire human kinome.J Chem Inf Model. 2012 Jan 23;52(1):156-70. doi: 10.1021/ci200314j. Epub 2012 Jan 6. J Chem Inf Model. 2012. PMID: 22133092
-
Chemical fragments as foundations for understanding target space and activity prediction.J Med Chem. 2008 May 8;51(9):2689-700. doi: 10.1021/jm701399f. Epub 2008 Apr 4. J Med Chem. 2008. PMID: 18386916
-
Inhibitors of phosphoinositide-3-kinase: a structure-based approach to understanding potency and selectivity.Org Biomol Chem. 2009 Mar 7;7(5):840-50. doi: 10.1039/b819067b. Epub 2009 Jan 8. Org Biomol Chem. 2009. PMID: 19225663 Review.
-
Kinase selectivity profiling by inhibitor affinity chromatography.Expert Rev Proteomics. 2004 Oct;1(3):303-15. doi: 10.1586/14789450.1.3.303. Expert Rev Proteomics. 2004. PMID: 15966827 Review.
Cited by
-
Potential of protein kinase inhibitors for treating herpesvirus-associated disease.Trends Microbiol. 2013 Jun;21(6):286-95. doi: 10.1016/j.tim.2013.03.005. Epub 2013 Apr 19. Trends Microbiol. 2013. PMID: 23608036 Free PMC article. Review.
-
Modulation of Src Kinase Activity by Selective Substrate Recognition with Pseudopeptidic Cages.Chemistry. 2021 Jul 2;27(37):9542-9549. doi: 10.1002/chem.202100990. Epub 2021 Jun 1. Chemistry. 2021. PMID: 33904620 Free PMC article.
-
The kinase inhibitor tofacitinib in patients with rheumatoid arthritis: latest findings and clinical potential.Ther Adv Musculoskelet Dis. 2013 Feb;5(1):3-11. doi: 10.1177/1759720X12470753. Ther Adv Musculoskelet Dis. 2013. PMID: 23515130 Free PMC article.
-
PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis.Clin Cancer Res. 2024 Jan 17;30(2):450-461. doi: 10.1158/1078-0432.CCR-23-2313. Clin Cancer Res. 2024. PMID: 37943631 Free PMC article.
-
Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.Cancer Discov. 2012 May;2(5):458-71. doi: 10.1158/2159-8290.CD-11-0284. Epub 2012 Mar 31. Cancer Discov. 2012. PMID: 22588883 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Molecular Biology Databases